From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...
So this is a drug that's still in development. So this is GS-1720. It's been studied as single doses in healthy volunteers ...
Hosted on MSN6h
Gilead reports positive HIV PrEP data for lenacapavirGilead Sciences (NASDAQ:GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention ...
Westport failed to provide a resident medication to treat advanced HIV for three weeks, resulting in "significant medication ...
GEORGETOWN, Guyana (CMC) — The Pan American Health Organization (PAHO) says approximately 5,100 people die annually in the ...
People on MSN8d
Man Born with HIV Shares How He and His Wife Are Expecting an HIV-Negative Baby: 'I Was Able to Break a Cycle' (Exclusive)Joseph Kibler and his wife, Carey Cox, shared that they're expecting a baby who will be HIV-negative, despite Kibler's ...
WSAV Savannah on MSN4h
World AIDs Day: Coastal Health District to offer free HIV testing events in SavannahIn honor of World AIDs Day, the Coastal Health District (CHD) is offering three free HIV testing events in Savannah. At two ...
Serious questions are being raised about what led to the limited supply of crucial HIV medication, prompting the Health ...
A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...
The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...
HIV is an infection that can be transmitted from one person to another through sexual activity, such as anal, oral, or ...
(HealthDay News) — The supply of health care professionals available to provide HIV care is expected to continue to decline over the next 5 years, according to research published in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback